Results 81 to 90 of about 2,421 (106)

Commentary: Internal medicine at the crossroads of long COVID diagnosis and management. [PDF]

Front Med (Lausanne)
Spanoghe M, Molmans THJ, Antonacci T, Burel E, Herschke F, Schneider N, Oustric P, Thielemans P, Nicolas JB, Dauby N, Nicaise C, Van Weyenbergh J, Jamoulle M.   +12 more
europepmc   +1 more source

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study. [PDF]

Haematologica
Chalopin T, Hulin C, Royer B, Bastie JN, Bobin A, Merzoug KB, Macro M, Karlin L, Jacquet C, Mohty M, Frenzel L, Sonntag C, Fontan J, Rigaudeau S, Roussel M, Sanhes L, Chaoui D, Vincent L, Orfeuvre H, Bouketouche M, Garlantezec R, Decaux O, Perrot A.   +22 more
europepmc   +1 more source

High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing. [PDF]

Blood
Schavgoulidze A, Perrot A, Leleu X, Cazaubiel T, Chretien ML, Feugier P, Belhadj K, Manier S, Roussel M, Brechignac S, Orsini-Piocelle F, Mohty M, Schiano de Collela JM, Macro M, Adiko D, Dib M, Fontan J, Luttiau-Motard C, Bouscary D, Pascal L, Roland V, Lifermann F, Bakala J, Montes L, Kennel C, Rey P, Richez V, Keddar F, Frenzel L, Calmettes C, Chaleteix C, Plantier I, Chalayer E, Schmitt A, Roul C, Demarquette H, Cerutti C, Pavageau L, Derrier L, Avet-Loiseau H, Corre J.   +40 more
europepmc   +1 more source

Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia? [PDF]

Leukemia
Selimoglu-Buet D, Chevret S, Santini V, Thépot S, Morabito M, Adès L, Laplane L, Giagounidis A, Droin N, Lübbert M, Sapena R, Nimubona S, Torregrosa-Diaz JM, Germing U, Pelizzari AM, Park S, Jaekel N, Metzgeroth G, Onida F, Paul F, Patriarca A, Stamatoullas A, Götze K, Chermat F, Platzbecker U, Fenaux P, Solary E, Itzykson R.   +27 more
europepmc   +1 more source

Thrombopénie récurrente avec agrégation plaquettaire chez une femme enceinte. [PDF]

CMAJ
Khalife R, Mahdi T, Tinmouth A.
europepmc   +1 more source

EASIX score is predictive of early fatal complications in newly diagnosed acute myeloid leukemia. [PDF]

Ann Hematol
Finotto T, Tauveron-Jalenques U, Barrière S, Adelou S, Futier E.   +4 more
europepmc   +1 more source

Stage I placental site trophoblastic tumor with complete response after pembrolizumab. [PDF]

Gynecol Oncol Rep
Descargues P, Eiriksson LR, Rousset P, Msika A, You B, Trecourt A, Massardier J, Hajri T, Borghese B, Golfier F, Bolze PA, Alexandre J.   +11 more
europepmc   +1 more source

Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors. [PDF]

Hemasphere
Stammler R, Chen P, Debeaupuis O, Zhao LP, Ruyer-Thompson M, Zakine E, Rossignol J, Goldwirt L, Comont T, Heiblig M, Adès L, Sebert M, Allain JS, Campagne J, Couturier MA, Cumin M, Dalmas MC, Denis G, Devloo C, De Voeght A, Drevon L, Duffau P, Georgin-Lavialle S, Gobert D, Kosmider O, Rieux-Laucat F, Abisror N, Lazaro E, Lopez JG, Maria A, Mauhin W, Merindol J, Merlot C, Mirault T, Pascal L, Perrin F, Raffoux E, Rahme R, Roos-Weil D, Terrier B, Thoreau B, Fain O, Fenaux P, Hirsch P, Jachiet V, Hadjadj J, Mékinian A, MINHEMON.   +47 more
europepmc   +1 more source

Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM. [PDF]

Br J Haematol
D'Aveni M, Schenone L, Torregrosa JM, Pardo J, Stamatoullas A, Saillard C, Thépot S, Dimicoli S, Santana C, Daguindau E, Paul F, Le Clech L, Park S, Cluzeau T, Paubelle E, Taksin-Bressot AL, Chermat F, Adès L, Fenaux P, Comont T.   +19 more
europepmc   +1 more source

Thrombopénie isolée chez une femme enceinte de 32 ans. [PDF]

CMAJ
Yi Y, Duffett L, Choi YJ, Khalife R.
europepmc   +1 more source